Target intelligence / Profile preview

Severe fever with thrombocytopenia syndrome virus glycoprotein Gn (SFTSV Gn) (SFTSV Gn)

Target
SFTSV Gn
Molecular classification
Viral surface glycoprotein, Receptor-binding protein, Type I transmembrane protein
01

Overview

The Severe fever with thrombocytopenia syndrome virus (SFTSV) glycoprotein Gn is a critical structural component of the viral envelope, primarily responsible for host cell attachment and entry (Wu et al., 2017, PMID: 28978461). SFTSV, a member of the Bandavirus genus (recently reclassified as Dabie bandavirus), causes a severe tick-borne illness characterized by high fever, thrombocytopenia, and multi-organ failure, with mortality rates ranging from 12% to 30% (Yu et al., 2011, PMID: 21410387). The Gn protein forms heterodimers with the Gc protein on the virion surface, where the Gn ectodomain serves as the primary target for the host's neutralizing antibody response (Kim et al., 2019, PMID: 30700611). Research indicates that the Gn ectodomain contains the receptor-binding domain (RBD) that interacts with host factors like DC-SIGN and L-SIGN to facilitate viral internalization via endocytosis (Hofmann et al., 2013, PMID: 23760237). Because of its accessibility on the viral surface and its essential role in the infection cycle, the Gn ectodomain is a focal point for the development of vaccines and therapeutic monoclonal antibodies, such as MAb 4-5 and Sabin-1, which aim to neutralize the virus by blocking its ability to infect susceptible host cells.

Other names
Dabie bandavirus glycoprotein GnSFTSV Gn ectodomainGlycoprotein NSFTSV G1 proteinSFTS virus glycoprotein Gn
02

Mechanism of action

Neutralization of viral infectivity by binding to the Gn ectodomain, which sterically hinders the interaction between the virus and host cell receptors (such as DC-SIGN) and inhibits subsequent viral entry and membrane fusion.

03

Biological functions

Viral attachmentHost cell receptor bindingViral entryHost cell recognitionVirion assembly
04

Disease associations

InfectionSevere fever with thrombocytopenia syndrome (SFTS)
05

Safety considerations

Antibody-dependent enhancement (ADE) of infectionViral mutational escape (antigenic drift)High sequence variability across different bandavirus strains
06

Interacting drugs

MAb 4-5 (Experimental)

4 more in the full profile.

07

Biomarkers

Anti-SFTSV Gn IgG/IgM antibodiesSFTSV RNA (viral load)Serum Gn antigen levels

Beyond the preview

Go deeper on Severe fever with thrombocytopenia syndrome virus glycoprotein Gn (SFTSV Gn) (SFTSV Gn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe fever with thrombocytopenia syndrome virus glycoprotein Gn (SFTSV Gn) (SFTSV Gn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call